Skip to content

Clinical trial of analgesic Effect of intraperitoneal bupivacaine-petidine infiltration compared with intravenous paracetamol on Post gynecologic diagnostic laparoscopic pain

Clinical trial of analgesic effect of intraperitoneal Bupivacaine-Petidine infiltration compared with intravenous after diagnostic gynecologic laparpscopy

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013072810765N4
Enrollment
90
Registered
2014-02-22
Start date
2014-02-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Change in pain after laparoscopy.

Interventions

Intervention 1: The patients in group 1 will receive Paracetamol 1 g IV and normal saline intraperitoneal, 10 minutes before the end of operation. Intervention 2: Group 2 will receive normal saline I
Treatment - Drugs
The patients in group 1 will receive Paracetamol 1 g IV and normal saline intraperitoneal, 10 minutes before the end of operation
Group 2 will receive normal saline IV and intraperitoneal bupivacaine 0.25%, 40ml –pethidine 50 mg, 10 minutes before the end of operation.

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 38 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:Women with 20-38 years old; candidated for gynecologic diagnostic Laparoscopy; patients with ASA physical status I and II; patients who will give written informed consent Exclusion criteria: Women with ASA physical status III or higher;patients who received analgesic; patients who had contraindication for NSAIDs or Paracetamol like peptic ulcer; coagulopathy; renal failure;hepatic failure; allergy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Postoperative pain. Timepoint: 2, 4, 6, 8, 12, 24 hours postoperative. Method of measurement: with the use of visual Analogue Scale.

Secondary

MeasureTime frame
Sedation. Timepoint: 2, 4, 6, 8, 12, 24 hours post operative. Method of measurement: with the use of modified Ramssy sedation scoring.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Sousan Rasooli

Alzahra Hospital

Rasooli_s@yahoo.com+98 41 1553 9161

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026